Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Journal of Pharmaceutical Sciences|June 11, 2011
A formulation-enabled preclinical efficacy assessment of a farnesoid X receptor agonist, GW4064, in hamsters and cynomolgus monkeysPo-Chang Chiang, David C Thompson, Sarbani Ghosh, et al.
Chemico-Biological Interactions|November 20, 2012
Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cellsVasilis Vasiliou, David C Thompson, Clay Smith, et al.
Journal of Chemical Information and Modeling|July 22, 2009
GARD: a Generally Applicable Replacement for RMSDJ Christian Baber, David C Thompson, Jason B Cross, et al.
Environmental Health and Preventive Medicine|October 8, 2016
Roles of defective ALDH2 polymorphism on liver protection and cancer developmentAkiko Matsumoto, David C Thompson, Ying Chen, et al.
Pharmaceutical Research|November 22, 2014
Human ALDH1B1 polymorphisms may affect the metabolism of acetaldehyde and all-trans retinaldehyde--in vitro studies and computational modelingBrian C Jackson, Philip Reigan, Bettina Miller, et al.
The Journal of Chemical Physics|June 17, 2008
Numerical integration of exchange-correlation energies and potentials using transformed sparse gridsJuan I Rodríguez, David C Thompson, Paul W Ayers, et al.
Progress in Retinal and Eye Research|October 27, 2012
Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance of transparency for visionYing Chen, David C Thompson, Vindhya Koppaka, et al.
Advances in Experimental Medicine and Biology|October 27, 2018
Glutathione and Transsulfuration in Alcohol-Associated Tissue Injury and CarcinogenesisYing Chen, Ming Han, Akiko Matsumoto, et al.
Pageof 14